Post-TRIPS Patenting Trends in India with Special Reference to USA: A Comparative Analysis
8 Pages Posted: 18 Jan 2012
Date Written: June 20, 2011
Abstract
The TRIPs Agreement, it was projected would prove beneficial for the developing countries, as it would foster innovation, stimulate competitiveness, promote transfer of technology and encourage investment and international trade. India being a signatory to TRIPs Agreement amended its patent legislation to comply with the obligations under it. After having become fully compliant with TRIPs, one now needs to examine how far has TRIPs contributed in fostering inventive activity in India, specially with reference to USA, a very strong advocate of TRIPs Agreement. The patenting data worldwide and the relevant data from USA and India is compared and analyzed so as to find out the exact trend. The study shows that there is a tremendous growth in patenting in India after the implementation of TRIPs. But the inventive growth in India has not seen an upward spurt as expected. Most of the patents in India are owned by foreign inventors, mostly from USA, indicating that TRIPs has benefited USA and other developed countries. On the contrary, India has a negligible share in patents granted in USA. The patenting trend in India shows that TRIPs has neither encouraged innovation in India nor has it played any major role in the development of India.
Keywords: Intellectual Property, TRIPs, Patenting Trend, Inventions, Innovation
Suggested Citation: Suggested Citation
Do you have a job opening that you would like to promote on SSRN?
Recommended Papers
-
Liberalization, Firm Size and R&D Performance: A Firm Level Study of Indian Pharmaceutical Industry
-
FDI Spillovers and Local Productivity Growth: Evidence from Indian Pharmaceutical Industry
-
Global Competitiveness of Indian Pharmaceutical Industry: Trends and Strategies
-
Global Competitiveness of Indian Pharmaceutical Industry: Trends and Strategies
-
By Giovanni Balcet and Silvia Bruschieri
-
Structure and Performance of Small and Medium Scale Pharmaceutical Firms
-
Non-Equity Operation of Multinational Enterprises in India: Focus on Outsourcing
By Jaya Pradhan
-
The Government as an Actor in Innovation: How the Indian Government Stimulates Innovation